US 11,806,443 B2
Cartilage-derived implants and methods of making and using same
Michael A. Nasert, Hazlet, NJ (US); Florence Stoffel, Whitehouse Station, NJ (US); Paul R. Williams, Boise, ID (US); and Alex Callahan, Eatontown, NJ (US)
Assigned to Musculoskeletal Transplant Foundation, Edison, NJ (US)
Filed by Musculoskeletal Transplant Foundation, Edison, NJ (US)
Filed on May 21, 2021, as Appl. No. 17/327,107.
Application 17/327,107 is a continuation of application No. 15/236,975, filed on Aug. 15, 2016, granted, now 11,052,175.
Claims priority of provisional application 62/207,146, filed on Aug. 19, 2015.
Prior Publication US 2021/0275722 A1, Sep. 9, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 27/36 (2006.01); B29C 65/56 (2006.01); B29B 13/04 (2006.01); B29L 31/00 (2006.01)
CPC A61L 27/3612 (2013.01) [A61L 27/3654 (2013.01); B29B 13/04 (2013.01); B29C 65/565 (2013.01); A61L 2430/06 (2013.01); B29K 2995/0056 (2013.01); B29L 2031/7532 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A cartilage-derived implant for treating a cartilage defect, said implant comprising a plurality of cartilage fibers which are elongated pieces of cartilage tissue, each having three or more laterally oriented striations, wherein the striations of the cartilage fibers enable the cartilage fibers to entangle with one another to a greater degree than cartilage fibers without such striations and to form the implant which is capable of retaining its shape until reshaped and of conforming to and filling the cartilage defect when implanted in the cartilage defect.